Dalton Cooper is the Managing Editor of Game Rant. Dalton has been writing about video games professionally since 2011. Having written thousands of game reviews and articles over the course of his ...

'EPiC' made its world premiere at the 2025 Toronto International Film Festival and will hit theaters in 2026. By Pamela McClintock Senior Film Writer EPiC will hit theaters in 2026, with Neon handling ...

TORONTO – Baz Luhrmann made his version of Elvis Presley's legend with "Elvis." And with his latest movie, the director lets the King of Rock 'n' Roll tell his own story. When getting ready to make ...

The FDA says shortages of GLP-1s are over, but many patients are still getting what are essentially copied medications. The market for drugs that treat obesity and help people lose weight is soaring.

Flush with funding and surging demand, compounding pharmacies are attracting capital from private equity firms, venture capital firms, and hospitals, reshaping the pharmaceutical power dynamic from ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk has notched ...

If you’ve received medication through popular telemedicine companies like Hims & Hers Health, you’re probably familiar with drug compounding. That’s the process of creating customized medicine for a ...

As of April 22, many compounding pharmacies will have to stop selling their own versions of the popular weight loss drugs Ozempic and Wegovy. That’s because the FDA has determined the shortage of ...

Ready to laugh and learn? Join me for a fun and epic tutorial on backwards ice skating! #IceSkating #BackwardsSkating #IceSkatingTutorial Trump unveils $5 million 'gold card' while aboard Air Force ...

ABC News' Dr. Tara Narula shares what patients need to know. Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S.

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision filed ...